Can group medical clinics improve lipid management in diabetes?

American Journal of Medicine

Volumn 127, Issue 2, 2014, Pages 145-151

  Crowley, Matthew J ^a,b   Melnyk, Stephanie D ^a,c   Ostroff, Jared L ^a   Fredrickson, Sonja K ^d   Jeffreys, Amy S ^a,e   Coffman, Cynthia J ^a,e   Edelman, David ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical inertia; Diabetes; Dyslipidemia; Group medical clinics; Treatment intensification

Indexed keywords

EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE CONTROL; DYSLIPIDEMIA; FEMALE; GROUP MEDICAL CLINIC; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; VETERAN;

CLINICAL INERTIA; DIABETES; DYSLIPIDEMIA; GROUP MEDICAL CLINICS; TREATMENT INTENSIFICATION;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME; VETERANS;

EID: 84893006362     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.09.027     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011 2011 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA
2. American Diabetes Association Economic Costs of Diabetes in the U.S. in 2012 Diabetes Care 36 4 2013 1033 1046
3. T.P. Gilmer, P.J. O'Connor, and W.A. Rush et al. Predictors of health care costs in adults with diabetes Diabetes Care 28 2005 59 64
4. H.M. Colhoun, D.J. Betteridge, and P.N. Durrington et al. CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial Lancet 364 2004 685 696
5. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial Lancet 361 2003 2005 2016
6. D. Schmucker Group Medical Appointments: An Introduction for Health Professionals 2006 Jones & Bartlett Sudbury, MA
7. Edelman D, McDuffie JR, Oddone E, Gierisch JM, Nagi A, Williams JW Jr. Shared Medical Appointments for Chronic Medical Conditions: A Systematic Review [VA-ESP Project #09-010; 2012]. Available at: http://www.hsrd.research.va.gov/ publications/esp/shared-med-appt.pdf. Accessed September 20, 2013.
8. E.H. Wagner, L.C. Grothaus, and N. Sandhu et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial Diabetes Care 24 2001 695 700
9. M. Trento, P. Passera, and M. Tomalino et al. Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up Diabetes Care 24 2001 995 1000
10. D.E. Clancy, D.W. Cope, K.M. Magruder, P. Huang, K.H. Salter, and A.W. Fields Evaluating group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes Diabetes Educ 29 2003 292 302
11. M. Trento, P. Passera, and E. Borgo et al. A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes Nutr Metab Cardiovasc Dis 15 2005 293 301
12. M. Trento, S. Gamba, L. Gentile ROMEO Investigators Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes Diabetes Care 33 2010 745 747
13. T.H. Taveira, P.D. Friedmann, and L.B. Cohen et al. Pharmacist-led group medical appointment model in type 2 diabetes Diabetes Educ 36 2010 109 117
14. T.H. Taveira, A.G. Dooley, L.B. Cohen, S.A. Khatana, and W.C. Wu Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults Ann Pharmacother 45 2011 1346 1355
15. L.B. Cohen, T.H. Taveira, S.A. Khatana, A.G. Dooley, P.A. Pirraglia, and W.C. Wu Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes Diabetes Educ 37 6 2011 801 812
16. D. Edelman, S.K. Fredrickson, and S.D. Melnyk et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial Ann Intern Med 152 2010 689 696
17. M.J. Crowley, S.D. Melnyk, C.J. Coffman, A.S. Jeffreys, and D. Edelman The impact of baseline insulin regimen on glycemic response to a group medical clinic intervention Diabetes Care 36 7 2013 1954 1960
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
19. M.E.B. Smith, N.J. Lee, E. Haney, and S. Carson Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5 2009 Oregon Health & Science University Portland, OR
20. S. Bent, A. Padula, and A.L. Avins Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial Ann Intern Med 144 2006 257 261
21. G. Verbeke, and G. Molenberghs Linear Mixed Models for Longitudinal Data 2000 Springer-Verlag New York
22. R.J. Little, and D.B. Rubin Statistical Analysis with Missing Data 2002 J Wiley Hoboken NJ
23. P.J. Diggle, P. Heagerty, K.Y. Liang, and S.L. Zeger Analysis of Longitudinal Data 2002 Oxford University Press Oxford
24. S.S. Virani, L.D. Woodard, and S.S. Chitwood et al. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease Am Heart J 162 4 2011 725 732
25. K.C. Goldberg, S.D. Melnyk, and D.L. Simel Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol Am J Manag Care 13 9 2007 530 534
26. E.A. Kerr, B.J. Zikmund-Fisher, M.L. Klamerus, U. Subramanian, M.M. Hogan, and T.P. Hofer The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure Ann Intern Med 148 2008 717 727
27. S.D. Bolen, T.A. Samuels, and H.C. Yeh et al. Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension J Gen Intern Med 23 2008 543 550
28. M.L. Parchman, J.A. Pugh, R.L. Romero, and K.W. Bowers Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin Ann Fam Med 5 2007 196 201
29. P.C. Hicks, J.M. Westfall, and R.F. Van Vorst et al. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care Diabetes Care 29 2006 2580 2585
30. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591